ScholarIQanswers from OpenAlex

Cell therapy for ARDS: efficacy of endobronchial versus intravenous administration and biodistribution of MAPCs in a large animal model

PaperCitations, authors & open-access status

Cell therapy for ARDS: efficacy of endobronchial versus intravenous administration and biodistribution of MAPCs in a large animal model is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Cell therapy for ARDS: efficacy of endobronchial versus intravenous administration and biodistribution of MAPCs in a large animal model have?

ScholarIQcitation count

Cell therapy for ARDS: efficacy of endobronchial versus intravenous administration and biodistribution of MAPCs in a large animal model has 55 citations in the OpenAlex counts ScholarIQ stores.

When was Cell therapy for ARDS: efficacy of endobronchial versus intravenous administration and biodistribution of MAPCs in a large animal model published?

ScholarIQyear

Cell therapy for ARDS: efficacy of endobronchial versus intravenous administration and biodistribution of MAPCs in a large animal model has 2019 year in the ScholarIQ index.

What is the open-access status of Cell therapy for ARDS: efficacy of endobronchial versus intravenous administration and biodistribution of MAPCs in a large animal model?

ScholarIQoa status

Cell therapy for ARDS: efficacy of endobronchial versus intravenous administration and biodistribution of MAPCs in a large animal model has gold oa status in the ScholarIQ index.

What is the DOI of Cell therapy for ARDS: efficacy of endobronchial versus intravenous administration and biodistribution of MAPCs in a large animal model?

ScholarIQdoi

The DOI for Cell therapy for ARDS: efficacy of endobronchial versus intravenous administration and biodistribution of MAPCs in a large animal model is on the source record.

What is the PMID of Cell therapy for ARDS: efficacy of endobronchial versus intravenous administration and biodistribution of MAPCs in a large animal model?

ScholarIQpmid

The PMID for Cell therapy for ARDS: efficacy of endobronchial versus intravenous administration and biodistribution of MAPCs in a large animal model is on the source record.

What is the OpenAlex record for Cell therapy for ARDS: efficacy of endobronchial versus intravenous administration and biodistribution of MAPCs in a large animal model?

ScholarIQopenalex

The OpenAlex for Cell therapy for ARDS: efficacy of endobronchial versus intravenous administration and biodistribution of MAPCs in a large animal model is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial